A Mixed-Methods Approach to Understanding Barriers and Facilitators to Proactive Autoantibody Testing for Early-Stage Type 1 Diabetes Among U.S. Family Physicians and Pediatricians
OBJECTIVE Early detection of type 1 diabetes through islet autoantibody (IAb) testing can improve disease trajectory and reduce complications. To optimize efforts to improve IAb screening, research is needed to better understand the facilitators and barriers to screening among U.S. physicians. RESEARCH DESIGN AND METHODS This mixed-methods study, which used the Theoretical Domains Framework from implementation science, was designed to identify key barriers and facilitators to IAb screening among U.S. physicians, prioritize those barriers and facilitators to identify where efforts to support practice change are most needed, and link those barriers and facilitators to behavioral change techniques (BCTs) to improve screening behaviors. The qualitative phase included interviews with family medicine physicians (n = 15) and pediatricians (n = 15). The quantitative phase used maximum difference scaling to rank physicians’ (n = 200) facilitators and barriers and regression modeling to assess whether priority barriers and facilitators predict screening behavior. RESULTS Twelve key barriers and facilitators emerged (e.g., lacking awareness of presymptomatic IAb testing, believing presymptomatic testing would have negative impacts on patients). BCTs associated with these included feedback, persuasive communication, and self-monitoring. Family physicians prioritized knowledge gaps as a key barrier (e.g., not understanding the application of IAb testing in detecting presymptomatic type 1 diabetes), whereas pediatricians prioritized motivational barriers (e.g., IAb testing not being a high clinical priority). CONCLUSIONS Findings reveal new insights into U.S. physician screening behaviors for presymptomatic type 1 diabetes. These results could inform the development and implementation of targeted, actionable communication strategies and other interventions to support routine IAb testing.
Authors
- Jay H. Shubrook (ORCID: https://orcid.org/0000-0001-5173-2656)
- Richard J. Spiegel (ORCID: https://orcid.org/0009-0000-9390-5789)
- Shpetim Karandrea (ORCID: https://orcid.org/0000-0003-0366-1923)
- Tom Bregartner
- Marissa Mays-Verman
- Lauren Welch
- Daniel Rojas
- Eric Du
Institutions
- Touro University California (US)
Publication Details
- Journal
- Diabetes Obesity and Cardiometabolic CARE
- Published
- 2026-11-16
- DOI
- https://doi.org/10.2337/doc26-0089
- Primary Topic
- Health Policy Implementation Science
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi